For the first time ever, track and field gold medalists in the Paris Olympics will receive $50,000 prize money despite resistance from critics who claimed that it would undermine the spirit of the games.

Canyon Bicycles announced its collaboration with NBA star LeBron James and several other riders to promote its line of bicycles and inspire the next generation of cyclists regardless of terrain and preferences.

Craig Wright, an Australian who claims to be Bitcoin's inventor, has been referred to UK prosecutors for alleged perjury after a judge found he may have forged documents to support his claim of being Satoshi Nakamoto.

Chinese state-backed financial companies in Hong Kong demand employees to return portions of their bonuses, aligning with President Xi Jinping’s ‘common prosperity’ plan to reduce income inequality.

President Biden proposes a 5% cap on annual rent increases for large landlords to address housing costs and stabilize rents amid inflation concerns.

Republican Party presidential candidate Donald Trump announced on the first day of the Republican National Convention Monday (July 15) that he has chosen first-term Ohio senator JD Vance as his vice-presidential running mate, triggering reactions from business executives across multiple sectors.

In an era plagued by climate crises, social inequality, and economic uncertainty, visionary entrepreneur Kenneth W. Welch Jr. is rewriting the rules of corporate responsibility. His brainchild, "Global's Corporate Machine," a groundbreaking model blending business acumen with humanitarian aims to tackle the world's most pressing growth, development, economic, and detrimental challenges holding back or plaguing our "Planet, Head-on."

NeOnc, Technologies Holdings, Inc., a biotech company revolutionizing the treatment of brain cancer with its innovative delivery method, is breaking new ground once again by closing its most recent funding round at a $220 million valuation.

The market for GLP-1 (glucagon-like peptide-1) receptor agonists is quickly becoming a profitable investment option. Despite these medications' promising efficacy and expanding indications, the market faces significant challenges that need innovative solutions. Dr. Jonathan Kaplan, a renowned plastic surgeon and entrepreneur, has strategically positioned his company, BuildMyHealth, to tackle these obstacles and take advantage of the vast opportunities in the GLP-1 market.

Landing your dream job can transform your professional life and bring immense personal satisfaction, but it requires a strategic approach and the right resources.